Dishman Carbogen Amcis Ltd is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants with presence in Switzerland, UK, Europe, China and other countries.
Financial Results:
Dishman Carbogen Amcis Ltd reported Revenues for Q1FY25 of ₹524.00 Crores down from ₹723.00 Crore year on year, a fall of 27.52%.
Total Expenses for Q1FY25 of ₹598.00 Crores down from ₹700.00 Crores year on year, a fall of 14.57%.
Consolidated Net Profit of -₹78.00 Crores from ₹17.00 Crores in the same quarter of the previous year.
The Earnings per Share is -₹4.95, from ₹1.08 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.